Critical care management of infectious meningitis and encephalitis
Central nervous system (CNS) infections represent 2.9% of the infections encountered in the intensive care unit (ICU) . Among them, infectious meningitis and encephalitis, regardless of their community or healthcare-associated origin, often have dramatic consequences, including permanent brain injury and mortality. Due to the potential severity of presentation and the acute risk of mortality, many of these patients are admitted to the ICU. Their management requires a thorough understanding of not only epidemiology and diagnostic workup, but also of antimicrobial and adjunctive treatments.
Acute bacterial meningitis
The worldwide incidence of acute bacterial meningitis is highly variable depending on the region, ranging from 207.4 (95% UI 183.9–233.9) per 100,000 in South Sudan to as low as 0.5 (0.4–0.7) per 100,000 in Australia . Mortality is high, ranging from 17 to 40%, depending on causative pathogen and country income status. The global number of...
Compliance with ethical standards
Conflicts of interest
GM is funded by the Research Foundation, Flanders (FWO), as senior clinical investigator (1843118 N) and receives project research funding from the KU Leuven (C24/17/072); he has received consultancy and lecture fees from Codman. RS received grants from the French Ministry of Health, the French Society of Intensive Care Medicine (SRLF) and the European Society of Intensive Care Medicine (ESICM), and lecture fees from Baxter.
This article does not contain any studies involving animals or human participants performed by any of the authors. The review, and decisions on authorship, were performed in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.
- 9.Parikh SR, Andrews NJ, Beebeejaun K et al (2016) Effectiveness and impact of a reduced infant schedule of 4CMenB vaccine against group B meningococcal disease in England: a national observational cohort study. Lancet 388:2775–2782. https://doi.org/10.1016/S0140-6736(16)31921-3 CrossRefPubMedGoogle Scholar
- 12.Waight PA, Andrews NJ, Ladhani SN et al (2015) Effect of the 13-valent pneumococcal conjugate vaccine on invasive pneumococcal disease in England and Wales 4 years after its introduction: an observational cohort study. Lancet Infect Dis 15:535–543. https://doi.org/10.1016/S1473-3099(15)70044-7 CrossRefPubMedGoogle Scholar
- 14.Auburtin M, Wolff M, Charpentier J et al (2006) Detrimental role of delayed antibiotic administration and penicillin-nonsusceptible strains in adult intensive care unit patients with pneumococcal meningitis: The PNEUMOREA prospective multicenter study. Crit Care Med 34:2758–2765. https://doi.org/10.1097/01.CCM.0000239434.26669.65 CrossRefPubMedGoogle Scholar
- 20.Swinnen B, Saegeman V, Beuselinck K et al (2019) Predictive value of JC virus PCR in cerebrospinal fluid in the diagnosis of PML. Diagn Microbiol Infect Dis 95(3):114859. https://doi.org/10.1016/j.diagmicrobio.2019.06.011 CrossRefPubMedGoogle Scholar
- 27.Lozier AP, Sciacca RR, Romagnoli MF, Connolly ES (2002) Ventriculostomy-related infections: a critical review of the literature. Neurosurgery 51:170–182. https://doi.org/10.1227/01.NEU.0000017465.78245.6C CrossRefPubMedGoogle Scholar
- 42.Leber A, Everhart K, Demogines A et al (2015) Multi-center clinical evaluation of a multiplex meningitis / encephalitis pcr panel for simultaneous detection of bacteria, yeast, and viruses in cerebrospinal fluid specimens. J Clin Microbiol 54:2251–2261. https://doi.org/10.1128/JCM.00730-16.Editor CrossRefGoogle Scholar
- 68.Tafelski S, Wagner L, Angermair S, Deja M (2017) Therapeutic drug monitoring for colistin therapy in severe multi-resistant Acinetobacter intracerebral abscess: a single case study with high-dose colistin and review of literature. SAGE Open Med Case Rep 5:2050313X1771163. https://doi.org/10.1177/2050313x17711630 CrossRefGoogle Scholar
- 76.Zoons E, Weisfelt M, de Gans J et al (2008) Seizures in adults with bacterial meningitis. Neurology 70:2109–2115. https://doi.org/10.1212/01.wnl.0000288178.91614.5d CrossRefPubMedGoogle Scholar
- 80.Ajdukiewicz KMB, Cartwright KE, Scarborough M et al (2011) Glycerol adjuvant therapy in adults with bacterial meningitis in a high HIV seroprevalence setting in Malawi: a double-blind, randomised controlled trial. Lancet Infect Dis 11:293–300. https://doi.org/10.1016/S1473-3099(10)70317-0 CrossRefPubMedPubMedCentralGoogle Scholar